Primary Care Research Group, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, UK.
Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Int J Clin Pharm. 2019 Dec;41(6):1400-1407. doi: 10.1007/s11096-019-00907-2. Epub 2019 Sep 17.
Background People with visual impairment often report poorer health and encounter many challenges when using medicines. Pharmacists can play a significant role in optimising medicines use for these patients. However, little is known about pharmacists' current practices when providing services to this population nor the impact of such services, if any, on medicines optimisation-related outcomes. Aim of the review This systematic review aims to identify the types, and assess the effectiveness of, interventions provided by pharmacists on medicines optimisation-related outcomes. Method Systematic searches of the following electronic databases were carried out from date of inception to March 2018: Cochrane Library; MEDLINE; EMBASE; International Pharmaceutical Abstracts; Scopus; and Cumulative Index to Nursing and Allied Health Literature. Several trial registries and grey literature resources were also searched. Any randomised controlled trials, non-randomised controlled trials, controlled before-and-after studies, or interrupted time series analyses reporting on interventions provided by pharmacists to adult visually impaired patients and/or their caregivers in order to improve medicines optimisation-related outcomes of medicine safety, adherence, patient satisfaction, shared decision making, or quality of life were included. Results A total of 1877 titles/abstracts were screened, and 27 full text articles were assessed for eligibility. On examination of full texts, no studies met the inclusion criteria for this review. Conclusion This review highlights the need for future research that would be vital for promoting the safe and effective use of medicines and the delivery of pharmaceutical care services to people with visual impairment.
视力障碍人群常自述健康状况较差，在使用药物时也面临诸多挑战。药剂师在优化此类患者的药物使用方面可发挥重要作用。然而，目前人们对药剂师为该人群提供服务的实际操作以及此类服务对药物优化相关结局的影响知之甚少。
本系统评价旨在确定药剂师提供的干预措施的类型，并评估其对与药物优化相关结局的效果。
从各数据库建库时间至 2018 年 3 月，系统检索了 Cochrane Library、MEDLINE、EMBASE、国际药学文摘、Scopus 和 Cumulative Index to Nursing and Allied Health Literature 等电子数据库，还检索了多个试验注册库和灰色文献资源。纳入了报告以下干预措施的随机对照试验、非随机对照试验、对照前后研究或中断时间序列分析：药师为视力障碍成年患者及其照护者提供的干预措施，旨在改善药物安全性、用药依从性、患者满意度、共同决策或生活质量等与药物优化相关的结局。
共筛选出 1877 篇标题/摘要，并评估了 27 篇全文文章的纳入资格。经全文评估，没有研究符合本综述的纳入标准。
本综述强调了未来研究的必要性，这对于促进视力障碍人群安全有效用药以及提供药学护理服务至关重要。
